John G Ullman & Associates Inc. Sells 9,700 Shares of DENTSPLY SIRONA Inc. $XRAY

John G Ullman & Associates Inc. cut its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 38.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,800 shares of the medical instruments supplier’s stock after selling 9,700 shares during the quarter. John G Ullman & Associates Inc.’s holdings in DENTSPLY SIRONA were worth $251,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after buying an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of DENTSPLY SIRONA by 11.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in shares of DENTSPLY SIRONA by 4.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock valued at $180,445,000 after purchasing an additional 538,531 shares during the period. AQR Capital Management LLC raised its stake in shares of DENTSPLY SIRONA by 119.4% during the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after purchasing an additional 3,453,662 shares during the period. Finally, Edmond DE Rothschild Holding S.A. raised its stake in shares of DENTSPLY SIRONA by 26.4% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock valued at $43,526,000 after purchasing an additional 609,300 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $12.51 on Friday. The firm has a market capitalization of $2.50 billion, a P/E ratio of -2.64, a P/E/G ratio of 0.78 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The stock’s 50-day simple moving average is $13.38 and its two-hundred day simple moving average is $14.51. DENTSPLY SIRONA Inc. has a twelve month low of $11.69 and a twelve month high of $24.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. UBS Group decreased their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Finally, Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday. Two research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $18.00.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.